scPharmaceuticals SCPH 深 滬
已收盤 10-07 16:00:00 美东时间
5.67
0.000
0.00%
華盛通- 最 高--
- 今 開--
- 成交量 0股
- 最 低 --
- 昨 收 5.67
- 總市值 3.04亿
- 52周最高 6.2799
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 1.94
- 委 比 0.00%
- 總股本 5367.88万
- 歷史最高 18.17
- 量 比 0
- 振 幅 0.00%
- 歷史最低 1.94
- 每 手 1
- 風險率 1.15%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多MannKind Shares FUROSCIX® Business Updates
FDA approves FUROSCIX for pediatric patients weighing 43kg or above, expanding its use beyond adults with chronic heart failure and kidney disease. Additionally, five new patents for the FUROSCIX ReadyFlow Autoinjector provide extended intellectual property protection through 2040, reinforcing MannKind's position. The autoinjector, currently under FDA review, aims to deliver diuretic doses in seconds, potentially reducing hospital visits and impr...
2025-12-23 13:05
MannKind Announces U.S. FDA Accepts for Review its Supplemental New Drug Application (sNDA) of FUROSCIX ReadyFlow™ Autoinjector for the Treatment of Edema in Adults with Chronic Heart Failure or Chronic Kidney Disease
MannKind Corporation announced the FDA acceptance of the sNDA for FUROSCIX ReadyFlow Autoinjector, designed to deliver a subcutaneous furosemide dose in under 10 seconds for adult patients with chronic heart failure or kidney disease. If approved, it would offer a faster, more convenient alternative to the current 5-hour on-body infusor, potentially reducing hospital admissions and healthcare costs. The PDUFA target action date is July 26, 2026.
2025-12-01 13:05
scPharmaceuticals Completes Merger and Delists from Nasdaq
The latest update is out from scPharmaceuticals ( ($SCPH) ). On October 7, 2025...
2025-10-07 21:44
scPharmaceuticals Issues Promissory Note to MannKind
The latest update is out from scPharmaceuticals ( ($SCPH) ). On September 23, 2...
2025-09-25 16:25
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BRY, SCPH, WKHS on Behalf of Shareholders
NEW YORK, Sept. 22, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/o...
2025-09-22 20:46
美股大行评级 | 潜在涨幅163.16%！HIVE Digital Technologies获Roth Capital升目标价至7.5美元，维持"买入"评级
今日重点评级关注：Roth Capital：维持HIVE Digital Technologies"买入"评级，目标价从6美元升至7.5美元；Craig-Hallum：维持Ranpak Hldgs"买入"评级，目标价从8美元升至10美元
2025-08-27 08:32
Craig-Hallum Downgrades scPharmaceuticals to Hold, Announces $6 Price Target
Craig-Hallum analyst Chase Knickerbocker downgrades scPharmaceuticals (NASDAQ:SCPH) from Buy to Hold and announces $6 price target.
2025-08-27 02:01
Maxim Group Downgrades scPharmaceuticals to Hold
Maxim Group analyst Naz Rahman downgrades scPharmaceuticals (NASDAQ:SCPH) from Buy to Hold.
2025-08-26 02:57
MannKind, Backed By Blackstone, Expands Cardiorenal Focus With $360 Million Deal
MannKind will acquire scPharmaceuticals in a $360 million deal, adding Furoscix and expanding into cardiometabolic care with a $10 billion U.S. market opportunity.
2025-08-26 01:57
scPharmaceuticals Announces Merger with MannKind Corporation
The latest announcement is out from scPharmaceuticals ( ($SCPH) ). On August 24...
2025-08-25 19:59
